Regeneron sees Covid-19 treatment with results by April-end

Regeneron’s (NASDAQ:REGN) Kevzara, an arthritis treatment, could have results emanating from a portion of their trials related to treatment of COVID-19 by month-end.

Spokesperson noted that the enrollment is moving quickly, and had centered upon ill patients who were currently hospitalized due to coronavirus.

Update comes after Sanofi and REGN expanded their clinical trials earlier this week

https://seekingalpha.com/news/3558336-regeneron-sees-covidminus-19-treatment-results-april-end